Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma (Q39485439)

12 September 2017

title

Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma (English)

1 reference

12 September 2017

0 references

1 reference

Zhiqin Li

1

1 reference

12 September 2017

Hongyan Zhang

2

1 reference

12 September 2017

Jianping Yang

3

1 reference

12 September 2017

Tielai Hao

4

1 reference

12 September 2017

Shenglei Li

5

1 reference

12 September 2017

publication date

1 May 2012

1 reference

Cell Biology International

12 September 2017

published in

1 reference

12 September 2017

volume

36

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

427-432

1 reference

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Epigenetic gene silencing in cancer: the DNA hypermethylome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Chfr defines a mitotic stress checkpoint that delays entry into metaphase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Epigenetic silencing of the MGMT gene in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Epigenetic inactivation of CHFR in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Epigenetics of cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100851

21 January 2018

Identifiers

DOI

10.1042/CBI20100851

1 reference

12 September 2017

1 reference